Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy and Radiotherapy for NGGCT
NCT00047320Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jan 2004
- Primary completion
- Feb 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 5
01
Overview
A Phase 2 trial of carboplatin, etoposide, ifosfamide, thiotepa in intracranial non-germinomatous germ cell tumor (NGGCT), sponsored by Children's Oncology Group. Started Jan 2004; status: completed.
02
Drugs
carboplatinetoposideifosfamidethiotepa
03
Conditions
intracranial non-germinomatous germ cell tumor (NGGCT)
Beyond the preview
Go deeper on NCT00047320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047320.